Business Wire

CA-ANDERSEN-GLOBAL

20.9.2019 11:50:05 CEST | Business Wire | Pressemeddelelse

Del
Andersen Global udvider rækkevidde i London

Andersen Global fortsætter sin udvidelse i Storbritannien, idet Miles Dean, Zoe Wyatt og deres team slutter sig til Andersen Tax LLP-teamet i Storbritannien. Denne tilføjelse giver yderligere dybde til koncernen i London og forbedrer teamets evne til at arbejde sammen med kunder på en helhedsorienteret måde og yde uovertruffen og effektiv service. Andersen Global er repræsenteret fem steder i Storbritannien igennem sine medlems- og samarbejdsfirmaer.

Miles og Zoe har tidligere arbejdet for Milestone, som blev grundlagt af Miles Dean i 2008, og Zoe Wyatt blev partner i 2015. Som en del af Andersen Tax LLP vil disse partnere fortsat levere en bred vifte af internationale skattetjenester til virksomheder og private kunder, investeringsfonde og ejendomsinvestorer og -udviklere. Milestone underskrev en samarbejdsaftale med Andersen Global i 2018, og den positive indvirkning af dette forhold har ført til, at Miles, Zoe og deres team nu slutter sig til Andersen Global-medlemsfirmaet i Storbritannien.

“Det var enormt vigtigt for os at sikre, at vi er i stand til at yde det bedste for vores kunder. Vi ser virkelig frem til at fortsætte med at levere effektiv service og fordelen ved ekspertise fra de bedste rundt omkring i verden som en del af Andersen Global-familien,” sagde Miles Dean, grundlæggende partner hos Milestone og nu partner hos Andersen Tax LLP. “Jeg sætter pris på ​​at samarbejde med ligesindede partnere over hele kloden, og vores tid med Andersen Global, både som et samarbejdsfirma og nu som en del af det britiske medlemsfirma, har vist en fælles forpligtelse til at levere service af høj kvalitet.”

“At have Miles og Zoe som partnere i vores team er en naturlig udvikling, da vi har arbejdet tæt sammen med dem i mere end to år. Som en del af Andersen Tax LLP vil teamets komplementære ekspertise og erfaring give vores bredere koncern et markant løft på det dynamiske britiske marked, idet vi udvider vores rækkevidde i hele landet og globalt,” sagde George McCracken, administrerende direktør for Andersen Tax LLP.

“Miles, Zoe og deres team giver den slags unikke ekspertise og dedikation, der uden tvivl skiller sig ud fra resten. Teamet er indbegrebet af de egenskaber, som vi værdsætter hos Andersen, såsom gennemsigtighed, uovertruffen service og ledelse,” sagde Mark Vorsatz, bestyrelsesformand for Andersen Global og administrerende direktør for Andersen. “Idet vi fortsætter med at tilføje og udvide vores evner for kunder i Storbritannien, bygger vi videre på det eksisterende fundament i regionen og viser vores ildhu for at tilbyde effektive services over hele kloden.”

Andersen Global er en international sammenslutning af juridisk separate, uafhængige medlemsfirmaer, der består af skatte- og juraeksperter fra hele verden. Andersen Global blev etableret af det amerikanske medlemsfirma Andersen Tax LLC i 2013 og har nu over 4.500 eksperter verden over og er repræsenteret mere end 149 steder igennem medlems- og samarbejdsfirmaer.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye